News
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best mid cap growth stocks to invest in now. Earlier on June 5, ...
An efficient protocol has been developed using d-(2R)-Oppolzer sultam as a chiral auxiliary for generating anti/syn diastereomers with high enantiopurity and utilized in the efficient synthesis of ...
Aesculap Introduces XABO® Antibiotic-Impregnated Catheters for Hydrocephalus Treatment - Morningstar
The XABO Antibiotic-Impregnated Catheters offer enhanced infection control, with clinical studies showing a two-thirds reduction in shunt infection rates as compared to standard catheters. 4 The ...
There is increasing concern globally about the enormity of the threats posed by antimicrobial resistance (AMR) to human, animal, plant and environmental health. A proliferation of international, ...
A new drug could stop some breast cancer tumours from using hormones to grow, a trial has found. Results from the Serena-6 trial, carried out with the Institute of Cancer Research in London, ...
Drug overdose deaths are declining, but more than 80,000 Americans still die each year most often from opioids. Meanwhile, chronic pain affects one-third of the U.S. population. Research led by ...
But a new antibiotic from Swiss pharmaceutical company Roche could change the future of how we treat Gram-negative bacteria. Roche announced on Monday that its antibiotic zosurabalpin will enter ...
Drug kingpin Larry Hoover's federal prison sentence commuted by Trump Hoover and David Barksdale created the Gangster Disciples in the late 1960s, ruling as “King Larry” and “King David ...
Roche said on it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious hospital infections into the third and last phase of testing on humans.
Sartelli, M., Hardcastle, T.C., Catena, F., Chichom-Mefire, A., Coccolini, F., Dhingra, S., et al. (2020) Antibiotic Use in Low and Middle-Income Countries and the ...
May 28 (Reuters) - Spero Therapeutics (SPRO.O), opens new tab and partner GSK (GSK.L), opens new tab are stopping a late-stage trial of an experimental oral drug for complicated urinary tract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results